Clinical Drug Experience Knowledgebase

Anthrax

Lupus Erythematosus, Systemic

Anthrax (Phase 3)

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Colitis (Phase 1)

Colitis, Ulcerative (Phase 1)

Hepatitis (Phase 3)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 3)

Hepatitis, Chronic (Phase 3)

HIV Infections (Phase 1)

Lung Neoplasms (Phase 2)

Lupus Erythematosus, Systemic (Phase 4)

Lupus Nephritis (Phase 3)

Lymphoma (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Microscopic Polyangiitis (Phase 3)

Multiple Myeloma (Phase 2)

Neoplasms (Phase 1)

Neoplasms, Plasma Cell (Phase 2)

Nephritis (Phase 3)

Scleroderma, Diffuse (Phase 2)

Scleroderma, Systemic (Phase 2)

Sclerosis (Phase 2)

Sjogren's Syndrome (Phase 2)

Syndrome (Phase 2)

Ulcer (Phase 1)

Uterine Cervical Neoplasms (Phase 2)

Vasculitis (Phase 3)

Waldenstrom Macroglobulinemia (Phase 2)